Form 10-K NUVASIVE INC For: Dec 31
Tweet
Share
E-mail
http://archive.fast-edgar.com/20160211/APA2B22CZC22DT92222G2ZZ2LBACLY22R282
Filed on: February 11, 2016
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kura Oncology to Report First Quarter 2024 Financial Results
- XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
- Dynacor Group Declares May 2024 Dividend
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
